Antibiotic for treatment of a biothreat indication
Active Definitive Contract Awarded Last action
- Contract number
- 75A50120C00001
- Awardee
-
Paratek Pharmaceuticals, Inc. UEI D5KEFN62CJ97
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $265,316,226
Award facts
- Opportunity
-
- 19100SOL00011 Solicitation number
- Antibiotic Award Notice · Posted Dec 18, 2019
- Antimicrobial Solicitation · Posted May 8, 2019
- Antimicrobial Resistance Project Bioshield Pre-Solicitation · Posted Feb 14, 2019
- Contract value 87% obligated
-
- $265,316,226.00 Current, with exercised options
- $303,753,726.00 Potential, with all options
- Completion date 69% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- 4 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Boston, MA 02116, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $17,471,250 | |
| Supplemental Agreement for work within scope | $4,958,461 | |
| Supplemental Agreement for work within scope | $0 | |
| Change Order | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $17,471,250 | |
| Supplemental Agreement for work within scope | $807,986 | |
| Supplemental Agreement for work within scope | $0 | |
| Change Order | $36,398,438 | |
| Exercise an Option | $31,574,667 | |
| Supplemental Agreement for work within scope | $43,483 | |
| Exercise an Option | $97,210,132 | |
| Original award | $59,380,559 |
Show all 14
About this award
The U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a definitive firm fixed-price contract to Paratek Pharmaceuticals, Inc. valued at $303.8 million on December 18, 2019. The contract calls for the development and delivery of an antibiotic for the treatment of a biothreat indication, with performance to be completed by December 17, 2029. Paratek Pharmaceuticals will conduct work at its facility in Boston, Massachusetts. No set-aside designation was applied to this award.
This contract reflects ASPR's strategic focus on medical countermeasures and preparedness initiatives aimed at protecting the U.S. public health infrastructure against biological threats. The extended performance period through 2029 supports the development and production timelines typical of pharmaceutical advancement for specialized medical applications. Paratek Pharmaceuticals' selection as the prime contractor underscores the agency's commitment to engaging specialized pharmaceutical expertise to address critical public health security priorities in the biosecurity landscape.
Quick answers
Who was awarded contract 75A50120C00001?
75A50120C00001 was awarded to Paratek Pharmaceuticals, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on December 18, 2019.
How much is contract 75A50120C00001 worth?
The government has obligated $265,316,226 on 75A50120C00001. Its potential value, with all options, is $303,753,726.
Was contract 75A50120C00001 competed?
The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award